ITGB2 and pancreatic neoplasm: The present study describes the bright and selective labeling of pancreatic cancer in orthotopic mouse models implanted with the human pancreatic cancer cell lines SW1990 and CD18/HPAF using fluorescent MUC4 antibodies.